Annual Total Long Term Liabilities
$8.69 M
-$4.11 M-32.09%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual total long term liabilities is $8.69 million, with the most recent change of -$4.11 million (-32.09%) on December 31, 2022.
- During the last 3 years, ELOX annual total long term liabilities has fallen by -$2.23 million (-20.45%).
- ELOX annual total long term liabilities is now -32.09% below its all-time high of $12.80 million, reached on December 31, 2021.
Performance
ELOX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.62 M
-$714.00 K-21.39%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly total long term liabilities is $2.62 million, with the most recent change of -$714.00 thousand (-21.39%) on September 30, 2023.
- Over the past year, ELOX quarterly long term liabilities has dropped by -$7.56 million (-74.23%).
- ELOX quarterly long term liabilities is now -81.30% below its all-time high of $14.03 million, reached on March 31, 2019.
Performance
ELOX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ELOX Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.1% | -74.2% |
3 y3 years | -20.4% | -66.7% |
5 y5 years | +100.0% | +100.0% |
ELOX Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -32.1% | at low | -79.5% | at low |
5 y | 5-year | -32.1% | +35.6% | -79.6% | at low |
alltime | all time | -32.1% | -100.0% | -81.3% | -100.0% |
Eloxx Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $2.62 M(-21.4%) |
Jun 2023 | - | $3.34 M(-17.2%) |
Mar 2023 | - | $4.03 M(-53.6%) |
Dec 2022 | $8.69 M(-32.1%) | $8.69 M(-14.6%) |
Sep 2022 | - | $10.18 M(-12.4%) |
Jun 2022 | - | $11.63 M(-8.9%) |
Mar 2022 | - | $12.76 M(-0.3%) |
Dec 2021 | $12.80 M(+99.7%) | $12.80 M(-0.6%) |
Sep 2021 | - | $12.88 M(+170.7%) |
Jun 2021 | - | $4.76 M(-3.4%) |
Mar 2021 | - | $4.92 M(-23.2%) |
Dec 2020 | $6.41 M(-41.3%) | $6.41 M(-18.7%) |
Sep 2020 | - | $7.88 M(-11.1%) |
Jun 2020 | - | $8.86 M(-8.7%) |
Mar 2020 | - | $9.70 M(-11.2%) |
Dec 2019 | $10.93 M(>+9900.0%) | $10.93 M(-5.8%) |
Sep 2019 | - | $11.60 M(-9.5%) |
Jun 2019 | - | $12.82 M(-8.6%) |
Mar 2019 | - | $14.03 M(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(-100.0%) |
Jun 2018 | - | $91.00 K(>+9900.0%) |
Mar 2018 | - | $0.00(-100.0%) |
Dec 2017 | $0.00(-100.0%) | - |
Sep 2017 | - | $2.20 M(0.0%) |
Jun 2017 | - | $2.20 M(0.0%) |
Jun 2017 | $2.20 M(-48.8%) | - |
Mar 2017 | - | $2.20 M(0.0%) |
Dec 2016 | - | $2.20 M(-24.6%) |
Sep 2016 | - | $2.92 M(-32.0%) |
Jun 2016 | $4.30 M(-34.3%) | $4.30 M(-5.4%) |
Mar 2016 | - | $4.54 M(-28.5%) |
Dec 2015 | - | $6.35 M(+1.5%) |
Sep 2015 | - | $6.26 M(-4.4%) |
Jun 2015 | $6.54 M(+62.8%) | $6.54 M(+61.3%) |
Mar 2015 | - | $4.06 M(-0.2%) |
Dec 2014 | - | $4.07 M(+1.1%) |
Sep 2014 | - | $4.02 M(0.0%) |
Jun 2014 | $4.02 M(+3931.8%) | $4.02 M(+3931.8%) |
Mar 2014 | - | $99.70 K(0.0%) |
Dec 2013 | - | $99.70 K(0.0%) |
Sep 2013 | - | $99.70 K(0.0%) |
Jun 2013 | $99.70 K(-70.5%) | $99.70 K(-72.4%) |
Mar 2013 | - | $361.50 K(+178.1%) |
Dec 2012 | - | $130.00 K(-33.2%) |
Sep 2012 | - | $194.50 K(-42.5%) |
Jun 2012 | $338.50 K | $338.50 K(-32.7%) |
Mar 2012 | - | $502.60 K(-13.2%) |
Dec 2011 | - | $578.70 K(+7.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2011 | - | $539.30 K(-33.5%) |
Jun 2011 | $811.00 K(-68.8%) | $811.00 K(-16.1%) |
Mar 2011 | - | $967.00 K(-3.5%) |
Dec 2010 | - | $1.00 M(-23.3%) |
Sep 2010 | - | $1.31 M(-49.8%) |
Jun 2010 | $2.60 M(+2032.5%) | $2.60 M(+73.7%) |
Mar 2010 | - | $1.50 M(+54.0%) |
Dec 2009 | - | $972.50 K(-32.6%) |
Sep 2009 | - | $1.44 M(+1083.5%) |
Jun 2009 | $122.00 K(-0.7%) | $122.00 K(+2.2%) |
Mar 2009 | - | $119.40 K(-0.4%) |
Dec 2008 | - | $119.90 K(-1.1%) |
Sep 2008 | - | $121.20 K(-1.3%) |
Jun 2008 | $122.80 K(-4.7%) | $122.80 K(-87.0%) |
Mar 2008 | - | $943.80 K(+146.2%) |
Dec 2007 | - | $383.40 K(+173.7%) |
Sep 2007 | - | $140.10 K(+8.7%) |
Jun 2007 | $128.90 K(-3.9%) | $128.90 K(-1.0%) |
Mar 2007 | - | $130.20 K(-1.0%) |
Dec 2006 | - | $131.50 K(-1.0%) |
Sep 2006 | - | $132.80 K(-1.0%) |
Jun 2006 | $134.10 K(+45.0%) | $134.10 K(+6.3%) |
Mar 2006 | - | $126.10 K(+16.2%) |
Dec 2005 | - | $108.50 K(+8.0%) |
Sep 2005 | - | $100.50 K(+8.6%) |
Jun 2005 | $92.50 K(+2.7%) | $92.50 K(+2.7%) |
Mar 2005 | - | $90.10 K(0.0%) |
Dec 2004 | - | $90.10 K(0.0%) |
Sep 2004 | - | $90.10 K(0.0%) |
Jun 2004 | $90.10 K(0.0%) | $90.10 K(0.0%) |
Mar 2004 | - | $90.10 K(0.0%) |
Dec 2003 | - | $90.10 K(0.0%) |
Sep 2003 | - | $90.10 K(0.0%) |
Jun 2003 | $90.10 K(+32.5%) | $90.10 K(0.0%) |
Mar 2003 | - | $90.10 K(+13.9%) |
Dec 2002 | - | $79.10 K(0.0%) |
Sep 2002 | - | $79.10 K(+16.3%) |
Jun 2002 | $68.00 K(+48.5%) | $68.00 K(+19.5%) |
Mar 2002 | - | $56.90 K(0.0%) |
Dec 2001 | - | $56.90 K(+24.2%) |
Sep 2001 | - | $45.80 K(0.0%) |
Jun 2001 | $45.80 K(>+9900.0%) | $45.80 K(0.0%) |
Mar 2001 | - | $45.80 K(+332.1%) |
Dec 2000 | - | $10.60 K(0.0%) |
Sep 2000 | - | $10.60 K(0.0%) |
Mar 2000 | - | $10.60 K |
Jun 1999 | $0.00(0.0%) | - |
Jun 1998 | $0.00(0.0%) | - |
Jun 1997 | $0.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Eloxx Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Eloxx Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ELOX is $8.69 M
What is the all time high annual total long term liabilities for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual total long term liabilities is $12.80 M
What is Eloxx Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ELOX annual total long term liabilities has changed by -$4.11 M (-32.09%)
What is Eloxx Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ELOX is $2.62 M
What is the all time high quarterly long term liabilities for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly total long term liabilities is $14.03 M
What is Eloxx Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ELOX quarterly total long term liabilities has changed by -$7.56 M (-74.23%)